#$%^&*AU2011200464B220120809.pdf#####C : RPrtbr CC TXS0451317_ .DOC-402/20I I Inhalable Formulations For Treating Pulmonary Hypertension and Methods of Using Same Abstract 5 The present invention is directed to an inhalable formulation for the treatment of pulmonary hypertension in a mammal (e.g., humans), wherein the formulation comprises at least one hypertension reducing agent, including but not limited to an angiotensin converting enzyme inhibitor, angiotensin receptor blocker, beta-blocker, calcium-channel 10 blocker or vasodilator, or any combination thereof. The formulations of the present invention may be a solution or suspension, and preferably are suitable for administration via nebulization. The present invention is also directed to a method and kit for treating a mammal suffering from pulmonary hypertension.
